Introduction: Bladder cancer is the ninth common cancer in the world, the third common cancer among men in the Arabic and Western Asian countries, and the second in some regions of Iran (a country in the Middle East). There was no study on the epidemiological and histological trend of bladder cancer in Iran. This study aimed to the epidemiological and histological trend of bladder cancer in Iran. Materials and Methods: In this study, data were extracted from annual cancer registry reports of Iranian Ministry of Health between 2003 and 2008. Standardized incidence rates were calculated using the world standard population and incidence rate was calculated by age groups, sex, and histological type. Data on epidemiologic trend and histology wer...
Introduction: Study of cancer incidence trends can provide better insight for decision-making and co...
Skin cancer is one of the most common cancers worldwide, including in Iran. Awareness of trend and d...
Background: There are no population-based data available for cancer in Tehran, a city that includes ...
Introduction: Bladder cancer is the ninth common cancer in the world, the third common cancer among ...
BACKGROUND AND OBJECTIVE: Bladder cancers are common around the world that their incidence rate is d...
Objective: There are several reports related to the incidence of bladder cancer (BC) from various ge...
Objectives: The purpose of the study are to formulate an idea about the number of patients with blad...
OBJECTIVE: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing dea...
BACKGROUND : The aim of this study was to investigate the relationship between risk factors of bladd...
Background: Cancer is the third cause of death in Iran and its incidence is rising alarmingly. Howe...
Iran as a developing nation is in epidemiological transition from communicable to non-communicable d...
Abstract Background: Bladder cancer is the ninth most commonly diagnosed malignancy worldwide. The ...
Urinary bladder cancer is the main reason for morbidity and mortality throughout the world. Urotheli...
Background: Bladder cancer is diagnosed or treated worldwide in 2.7 million people each year (4%), a...
Background: Cancer is the second leading cause of death in developing countries. In Iran, cancer is ...
Introduction: Study of cancer incidence trends can provide better insight for decision-making and co...
Skin cancer is one of the most common cancers worldwide, including in Iran. Awareness of trend and d...
Background: There are no population-based data available for cancer in Tehran, a city that includes ...
Introduction: Bladder cancer is the ninth common cancer in the world, the third common cancer among ...
BACKGROUND AND OBJECTIVE: Bladder cancers are common around the world that their incidence rate is d...
Objective: There are several reports related to the incidence of bladder cancer (BC) from various ge...
Objectives: The purpose of the study are to formulate an idea about the number of patients with blad...
OBJECTIVE: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing dea...
BACKGROUND : The aim of this study was to investigate the relationship between risk factors of bladd...
Background: Cancer is the third cause of death in Iran and its incidence is rising alarmingly. Howe...
Iran as a developing nation is in epidemiological transition from communicable to non-communicable d...
Abstract Background: Bladder cancer is the ninth most commonly diagnosed malignancy worldwide. The ...
Urinary bladder cancer is the main reason for morbidity and mortality throughout the world. Urotheli...
Background: Bladder cancer is diagnosed or treated worldwide in 2.7 million people each year (4%), a...
Background: Cancer is the second leading cause of death in developing countries. In Iran, cancer is ...
Introduction: Study of cancer incidence trends can provide better insight for decision-making and co...
Skin cancer is one of the most common cancers worldwide, including in Iran. Awareness of trend and d...
Background: There are no population-based data available for cancer in Tehran, a city that includes ...